Atle van Beelen Granlund

Atle van Beelen Granlund is a Researcher in the Department of Clinical and Molecular Medicine at the Norwegian University of Science and Technology (NTNU). His work focuses on understanding genetic and molecular mechanisms underlying Inflammatory Bowel Disease (IBD) pathophysiology, particularly how gene variants and expression patterns relate to disease prognosis and treatment response. He collaborates extensively with clinical teams and other research units within the CAG-IBD group.

His research integrates large-scale genomic and transcriptomic analyses of patient-derived samples, including organoid cultures, to identify clinically actionable biomarkers. Key areas include epithelial cell biology, microbiome interactions, and the role of immune-modulating proteins like ISG15 and NGAL.

Recent publications (2020-2024) highlight studies on genetic variants associated with IBD severity, fungal mycobiome characterization in Crohn's disease, and drug testing using patient-derived colonoids. His work emphasizes translational applications to improve diagnostic precision and therapeutic strategies.

• PhD in Clinical and Molecular Medicine from NTNU (2013)
• Primary affiliation: Faculty of Medicine and Health Sciences
• Labs/Teams: CAG-IBD research group
• Focus areas: IBD genetics, biomarker development, epithelial immunology